Veracity Capital’s Pfizer PFE Stock Holding History

Veracity Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000	Closed	-$86K	–	271
2021 Q3	$86K	Hold	2,000	–	–	0.04%	241
2021 Q2	$78K	Sell	2,000 -2,000	-50%	-$77.8K	0.02%	250
2021 Q1	$144K	Buy	+4,000	New	+$142K	0.03%	241

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Veracity Capital's PFE Position: Q2 2024 in Review

Veracity Capital sold out of Pfizer (PFE) in Q2 2024, closing a stake of 7,425 shares — an estimated $206K sold.

Veracity Capital first reported a position in PFE in Q4 2019 and held it in 18 quarters. The position peaked at $985K in Q4 2019. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Veracity Capital reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
Veracity Capital sold 7,425 Pfizer shares in Q2 2024, an estimated $206K.
Veracity Capital first reported a position in Pfizer in Q4 2019 and held it in 18 quarters.
Veracity Capital's Pfizer position peaked at $985K in Q4 2019.
2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Veracity Capital's 13F filing for Q2 2024, filed 22 Jul 2024.